| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
623,250,000 |
| Market
Cap: |
18.28(B) |
| Last
Volume: |
1,481,256 |
Avg
Vol: |
1,477,160 |
| 52
Week Range: |
$27.6017 - $31.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : 5.8 |
| Insider 6 Months : 5.8 |
| Insider 3/6 Months : 12 |
|
| Guru Rank Number : 1033 |
| Guru Rank Value : -0.5 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Edwards Lifesciences is focused on technologies that treat structural heart disease and ill patients. The products and technologies provided by Co. are categorized into the several main areas, including: Transcatheter Aortic Valve Replacement, which is engaged in transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves; Transcatheter Mitral and Tricuspid Therapies, which is focused on the development of transcatheter heart valve repair and replacement technologies designed to treat mitral and tricuspid valve diseases; and Surgical Structural Heart, which is engaged in resilient surgical therapies.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
580 |
580 |
580 |
580 |
| Total Buy Value |
$49,753 |
$49,753 |
$49,753 |
$49,753 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
264,907 |
433,596 |
761,256 |
1,355,135 |
| Total Sell Value |
$23,346,662 |
$36,239,041 |
$61,949,910 |
$113,063,048 |
| Total People Sold |
9 |
11 |
11 |
13 |
| Total Sell Transactions |
20 |
33 |
64 |
113 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Valeriani Nicholas J |
Director |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,818 |
73,732 |
|
- |
|
| Laviolette Paul A |
Director |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,055 |
10,773 |
|
- |
|
| Loranger Steven R |
Director |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,054 |
60,372 |
|
- |
|
| Stone Leslie Heisz |
Director |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,055 |
30,035 |
|
- |
|
| Sequeira Ramona |
Director |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,055 |
8,158 |
|
- |
|
| Gallahue Kieran |
Director |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,054 |
4,054 |
|
- |
|
| Davis Leslie C. |
Director |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,055 |
3,055 |
|
- |
|
| Zovighian Bernard J |
CEO |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$55,053 |
D/D |
(647) |
79,689 |
|
- |
|
| Zovighian Bernard J |
CEO |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
33,500 |
80,336 |
|
- |
|
| Ullem Scott B. |
CVP, Chief Financial Officer |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$67,221 |
D/D |
(790) |
31,759 |
|
- |
|
| Ullem Scott B. |
CVP, Chief Financial Officer |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
11,075 |
32,549 |
|
- |
|
| Szyman Catherine M |
CVP, Critical Care |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$51,820 |
D/D |
(609) |
76,992 |
|
- |
|
| Szyman Catherine M |
CVP, Critical Care |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
32,025 |
77,601 |
|
- |
|
| Bobo Donald E Jr |
CVP,Strategy/Corp Development |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$52,671 |
D/D |
(619) |
47,750 |
|
- |
|
| Bobo Donald E Jr |
CVP,Strategy/Corp Development |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
48,369 |
|
- |
|
| Sellers Robert W.a. |
SVP, Corporate Controller |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$15,146 |
D/D |
(178) |
17,310 |
|
- |
|
| Sellers Robert W.a. |
SVP, Corporate Controller |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,445 |
17,488 |
|
- |
|
| Lemercier Jean-Luc M |
CVP, EMEACLA and JAPAC |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$3,914 |
D/D |
(46) |
184,789 |
|
- |
|
| Lemercier Jean-Luc M |
CVP, EMEACLA and JAPAC |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,125 |
184,835 |
|
- |
|
| Chopra Daveen |
CVP, TMTT |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$38,035 |
D/D |
(447) |
31,404 |
|
- |
|
| Chopra Daveen |
CVP, TMTT |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
31,851 |
|
- |
|
| Lippis Daniel J. |
CVP, JAPAC |
• • – |
2024-05-07 |
4 |
AS |
$85.60 |
$73,359 |
D/D |
(857) |
23,890 |
|
1% |
|
| Lippis Daniel J. |
CVP, JAPAC |
• • – |
2024-05-07 |
4 |
D |
$85.09 |
$49,863 |
D/D |
(586) |
24,747 |
|
- |
|
| Lippis Daniel J. |
CVP, JAPAC |
• • – |
2024-05-07 |
4 |
OE |
$36.75 |
$31,495 |
D/D |
857 |
25,333 |
|
- |
|
| Lippis Daniel J. |
CVP, JAPAC |
• • – |
2024-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,560 |
24,476 |
|
- |
|
2884 Records found
|
|
Page 1 of 116 |
|
|
0.06 (0.2%) 
